Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-type signatures of Alzheimer's disease shared across population groups.

Nature·2026
Same author

Neuroticism is linked to cognitive decline and increased risk of Alzheimer's disease through dysregulation of excitatory neurons.

bioRxiv : the preprint server for biology·2026
Same author

Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis.

bioRxiv : the preprint server for biology·2026
Same author

A TAD-informed aging-brain xQTL atlas of multi-modal and cell-type-resolved regulatory variation.

medRxiv : the preprint server for health sciences·2026
Same author

Innate immune signaling and functions in astrocytes.

Nature immunology·2026
Same author

Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.

Nature communications·2026

Related Experiment Video

Updated: Jun 10, 2025

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
06:12

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

1.2K

HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitro.

Verena Haage1, John F Tuddenham1,2, Alex Bautista1

  • 1Center for Translational & Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center.

Biorxiv : the Preprint Server for Biology
|October 17, 2024
PubMed
Summary

Researchers developed a new method to mimic human disease-associated microglia (DAM) using histone deacetylase (HDAC) inhibitors. This approach helps study DAM roles in neurodegenerative diseases and identify key marker genes.

Keywords:
Disease-associated microglia (DAM)functional analysishuman microgliain vitro model systems

More Related Videos

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

3.8K
A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
12:07

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation

Published on: September 19, 2010

23.7K

Related Experiment Videos

Last Updated: Jun 10, 2025

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
06:12

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

1.2K
Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

3.8K
A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
12:07

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation

Published on: September 19, 2010

23.7K

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Disease-associated microglia (DAM) are implicated in neurodegenerative diseases, with distinct subtypes (DAM1, DAM2) identified in mice.
  • The role of human DAM in neurodegeneration remains unclear, necessitating better in vitro models.
  • Single-cell RNA sequencing has confirmed DAM presence in humans, but their functional significance is debated.

Purpose of the Study:

  • To develop a pharmacological method for mimicking human disease-associated microglia (DAM) in vitro.
  • To functionally characterize the developed human DAM model.
  • To identify shared DAM marker genes across different studies and model systems.

Main Methods:

  • Utilized human microglia models exposed to specific histone deacetylase (HDAC) inhibitors.
  • Employed a pharmacological approach to induce a DAM phenotype in vitro.
  • Analyzed changes in gene expression, amyloid beta phagocytosis, and MCP-1 secretion.

Main Results:

  • Successfully mimicked human DAM in vitro using HDAC inhibitors.
  • Observed increased amyloid beta phagocytosis and reduced MCP-1 secretion in the model.
  • Identified MITF as a key transcription factor driving the DAM phenotype and validated CADM1, LIPA, and SCIN as shared DAM marker genes.

Conclusions:

  • The pharmacological strategy effectively models human DAM in vitro.
  • This approach facilitates the study of human DAM function and biology in neurodegeneration.
  • Identified novel and validated existing DAM marker genes, advancing the understanding of microglial responses.